Explore more publications!
Healthcare Brief Comoros
Got News to Share?

Healthcare Brief Comoros: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Brief Comoros.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 24, 2025

XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
December 24, 2025

XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

Indeterminate GlobeNewswire
LULUTOX Detox Tea in Consumer Coverage as Website Update Introduces More Transparency in Herbal Digestive Supplement Information
December 24, 2025

LULUTOX Detox Tea in Consumer Coverage as Website Update Introduces More Transparency in Herbal Digestive Supplement Information

Indeterminate GlobeNewswire
Mondelēz Global LLC Conducts Voluntary Recall of 2 SKUs of CHIPS AHOY! Baked Bites Brookie in the US
December 24, 2025

Mondelēz Global LLC Conducts Voluntary Recall of 2 SKUs of CHIPS AHOY! Baked Bites Brookie in the US

Indeterminate GlobeNewswire
Relapse Risk Increases During the Holidays; Desert Hope Treatment Center Urges Early Support
December 24, 2025

Relapse Risk Increases During the Holidays; Desert Hope Treatment Center Urges Early Support

Indeterminate GlobeNewswire
Profound Medical Corp. Announces Upsize of Private Placement
December 24, 2025

Profound Medical Corp. Announces Upsize of Private Placement

Indeterminate GlobeNewswire
ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain®
December 24, 2025

ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain®

Indeterminate GlobeNewswire
WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective December 29, 2025
December 24, 2025

WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective December 29, 2025

Indeterminate GlobeNewswire
Picard Medical Announces Up to $50 Million Senior Secured Debt Financing
December 24, 2025

Picard Medical Announces Up to $50 Million Senior Secured Debt Financing

Indeterminate GlobeNewswire
Clearmind Medicine Reflects on a Transformative 2025: Key Clinical Advancements, Expanded Global Reach, and Strengthened Foundation for Future Growth
December 24, 2025

Clearmind Medicine Reflects on a Transformative 2025: Key Clinical Advancements, Expanded Global Reach, and Strengthened Foundation for Future Growth

Indeterminate GlobeNewswire
S&P Global Ratings Upgrades Teva to ‘BB+’ Amid Strong Execution of Pivot to Growth Strategy; Moody's Ratings Agency Revises Outlook to Positive
December 24, 2025

S&P Global Ratings Upgrades Teva to ‘BB+’ Amid Strong Execution of Pivot to Growth Strategy; Moody's Ratings Agency Revises Outlook to Positive

Indeterminate GlobeNewswire
PharmAla Issues Audited Year End 2025 and Unaudited Q1 Fiscal 2026 Financial Statements
December 24, 2025

PharmAla Issues Audited Year End 2025 and Unaudited Q1 Fiscal 2026 Financial Statements

Indeterminate GlobeNewswire
MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings
December 24, 2025

MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings

Indeterminate GlobeNewswire
Human Appeal launches e-greeting card collection to support emergency charity projects
December 24, 2025

Human Appeal launches e-greeting card collection to support emergency charity projects

Indeterminate GlobeNewswire
Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline
December 24, 2025

Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline

Indeterminate GlobeNewswire
Communiqué de presse : Sanofi va acquérir Dynavax et ajouter un vaccin commercialisé contre l’hépatite B pour adultes et un candidat vaccin de phase 1⁄2 contre le zona au pipeline
December 24, 2025

Communiqué de presse : Sanofi va acquérir Dynavax et ajouter un vaccin commercialisé contre l’hépatite B pour adultes et un candidat vaccin de phase 1⁄2 contre le zona au pipeline

Indeterminate GlobeNewswire
Communiqué de presse : Sanofi fait le point sur la soumission réglementaire du tolebrutinib dans la sclérose en plaques secondaire progressive non-récurrente
December 24, 2025

Communiqué de presse : Sanofi fait le point sur la soumission réglementaire du tolebrutinib dans la sclérose en plaques secondaire progressive non-récurrente

Indeterminate GlobeNewswire
Press Release: Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
December 24, 2025

Press Release: Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis

Indeterminate GlobeNewswire
Best Peptides for Muscle Growth: Prescription Sermorelin Access, Injectable vs. Dissolving Tablets, and Realistic Expectations
December 24, 2025

Best Peptides for Muscle Growth: Prescription Sermorelin Access, Injectable vs. Dissolving Tablets, and Realistic Expectations

Indeterminate GlobeNewswire
U.S. FDA Approves Agios’ AQVESME™ (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia
December 24, 2025

U.S. FDA Approves Agios’ AQVESME™ (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions